92 related articles for article (PubMed ID: 23246419)
1. Evaluation of ethanolamine oleate sclerotherapy on the submandibular glands of canines as a potential therapy for sialorrhea.
Abbas F; Farid R; Nada I; El-Sharnouby M
Int J Pediatr Otorhinolaryngol; 2013 Mar; 77(3):351-5. PubMed ID: 23246419
[TBL] [Abstract][Full Text] [Related]
2. [Experimental studies on respiratory insufficiency after endoscopic injection sclerotherapy using ethanolamine-oleate].
Umekita N
Nihon Geka Gakkai Zasshi; 1986 Feb; 87(2):172-9. PubMed ID: 3713671
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Macroscopic Haemoglobinuria After Sclerotherapy Using Ethanolamine Oleate for Venous Malformations.
Fujiki M; Ozaki M; Kurachi I; Iwashina Y; Takushima A
Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):105-111. PubMed ID: 31133447
[TBL] [Abstract][Full Text] [Related]
4. Differences in hemostasis among sclerosing agents in endoscopic injection sclerotherapy.
Tatemichi M; Nagata H; Sekizuka E; Morishita T; Miyairi M; Tsuchiya M; Ishii H
Dig Dis Sci; 1996 Mar; 41(3):562-70. PubMed ID: 8617137
[TBL] [Abstract][Full Text] [Related]
5. [Disturbances of pulmonary gas exchange after sclerotherapy for esophageal varices].
Rusiniak K; Szczepanik AB; Ratajczak J; Meissner AJ
Wiad Lek; 1997; 50 Suppl 1 Pt 1():298-302. PubMed ID: 9446371
[TBL] [Abstract][Full Text] [Related]
6. Sclerotherapy for simple cysts with use of ethanolamine oleate: preliminary experience.
Yamamoto K; Sakaguchi H; Anai H; Tanaka T; Morimoto K; Kichikawa K; Uchida H
Cardiovasc Intervent Radiol; 2005; 28(6):751-5. PubMed ID: 16132390
[TBL] [Abstract][Full Text] [Related]
7. Injection of ethanolamine oleate into a segmental portal branch for pharmacologic hepatic segmentectomy in dogs.
Iwasaki T; Chida N; Suzuki S; Akahane T; Kobayashi N; Ishii M; Toyota T
Acad Radiol; 1995 Jun; 2(6):507-14. PubMed ID: 9419598
[TBL] [Abstract][Full Text] [Related]
8. Morphological and hemodynamic changes of the lung after injection of 5% ethanolamine oleate into dogs.
Iso Y; Kitano S; Iwanaga T; Hashizume M; Sugimachi K
Eur Surg Res; 1989; 21(3-4):175-83. PubMed ID: 2806345
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
[TBL] [Abstract][Full Text] [Related]
10. Ethanolamine oleate in resistant idiopathic achalasia: a novel therapy.
Niknam R; Mikaeli J; Mehrabi N; Mahmoudi L; Elahi E; Shirani S; Malekzadeh R
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1111-5. PubMed ID: 21971376
[TBL] [Abstract][Full Text] [Related]
11. Venous malformation of the tongue in a child treated by sclerotherapy with ethanolamine oleate: a case report.
Nishikawa M; Sakamoto K; Hidaka M; Yamashita A; Yamamoto G
J Pediatr Surg; 2006 Mar; 41(3):599-600. PubMed ID: 16516646
[TBL] [Abstract][Full Text] [Related]
12. Sclerotic effect of bleomycin on the submandibular gland: an experimental model.
Güçlü O; Muratli A; Arik D; Tekin K; Erdogan H; Dereköy FS
Int J Pediatr Otorhinolaryngol; 2013 Jun; 77(6):943-6. PubMed ID: 23548893
[TBL] [Abstract][Full Text] [Related]
13. Reactive vascular lesions treated using ethanolamine oleate sclerotherapy.
Hong SK; Lee HJ; Seo JK; Lee D; Hwang SW; Sung HS
Dermatol Surg; 2010 Jul; 36(7):1148-52. PubMed ID: 20533938
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109
[TBL] [Abstract][Full Text] [Related]
15. Salivary gland ablation: introducing an interventional radiology treatment alternative in the management of sialorrhea.
Begley KA; Braswell LE; Noritz GH; Murakami JW
Pediatr Radiol; 2020 May; 50(6):869-876. PubMed ID: 32198665
[TBL] [Abstract][Full Text] [Related]
16. Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy.
Ohta M; Hashizume M; Ueno K; Tanoue K; Sugimachi K
Hepatogastroenterology; 1993 Feb; 40(1):65-8. PubMed ID: 8462932
[TBL] [Abstract][Full Text] [Related]
17. [Effects of embolizing agent (ethanolamine oleate; EO) on esophageal varices with special reference to endothelial injury].
Masaki M; Mitsuhashi H; Kondo Y; Suzuki S; Wada T
Nihon Shokakibyo Gakkai Zasshi; 1984 Jun; 81(6):1491. PubMed ID: 6471550
[No Abstract] [Full Text] [Related]
18. Ethanolamine oleate sclerotherapy combined with transarterial embolization using n-butyl cyanoacrylate for extracranial arteriovenous malformations.
Kitagawa A; Izumi Y; Hagihara M; Kamei S; Ikeda S; Katsuda E; Kimura J; Ota T; Ishiguchi T
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):371-80. PubMed ID: 23737022
[TBL] [Abstract][Full Text] [Related]
19. What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?
Kato CN; Ribeiro MC; Abreu MH; Grossmann SD; Abreu LG; Caldeira PC; Mesquita RA
Med Oral Patol Oral Cir Bucal; 2020 Jul; 25(4):e468-e473. PubMed ID: 32388528
[TBL] [Abstract][Full Text] [Related]
20. Disseminated intravascular coagulation (DIC) after endoscopic injection sclerotherapy with ethanolamine oleate.
Bellary SV; Isaacs P
Endoscopy; 1990 May; 22(3):151. PubMed ID: 2357939
[No Abstract] [Full Text] [Related]
[Next] [New Search]
